Specify a stock or a cryptocurrency in the search bar to get a summary
SpectraCure AB
SPECSpectraCure AB (publ) engages in the development of cancer treatment system. It develops Q-PRO, a laser device; and IDOSE software with interstitial photodynamic therapy system for the treatment of prostate cancer. The company was incorporated in 2003 and is based in Lund, Sweden. Address: Gasverksgatan 1, Lund, Sweden, 222 29
Analytics
WallStreet Target Price
85.09 SEKP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures SPEC
Dividend Analytics SPEC
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
-5 %Dividend History SPEC
Stock Valuation SPEC
Financials SPEC
Results | 2019 | Dynamics |